Why Internal Tumor Motion Matters in Radiation Therapy
Beneath the surface, motion matters.
Radiation therapy demands precision. Yet among the many factors influencing treatment accuracy, respiratory tumor motion remains one of the most underappreciated challenges, especially in thoracic and abdominal sites.
While Surface Guided Radiation Therapy (SGRT) has improved patient setup and monitoring, it does not address the fundamental issue of tumor displacement caused by respiration. For deeper-seated mobile tumors, external surface tracking alone may provide a false sense of security.
Certainly, 4DCT/ITV free-breathing techniques are necessary for patients unable to perform breath-hold or with irregular breathing patterns; however, experience has shown that close to 90% of patients are able to use SDX®, with much to gain.
The Limits of Surface Tracking
SGRT systems are valuable tools for real-time patient positioning and motion detection, but they only track the external surface of the body. The positions of internal structures during a deep-inspiration breath-hold, including tumors, do not always move reproducibly in tandem with the skin.
This distinction is particularly important when treating cancers in the:
- Liver – Hepatocellular carcinoma (HCC)
- Upper Abdomen (Non-HCC)
- Pancreas
- Esophagus
- Thorax – (NSCLC – Lung)
- Mediastinum – Lymphoma
The AAPM Task Group Reports 290, 302, and 324 states that surface tracking is not a reliable surrogate. These task forces recommend the use of internal motion management strategies, such as internal verification imaging and spirometry-based respiratory gating, to ensure reproducibility of tumor location during radiation delivery.
If air volume in the lungs is not being measured after the verification image, how can one be certain that the tumor position is not drifting?
Data Drives Our Approach to Respiratory Motion Management
The SDX® Respiratory Gating System addresses this clinical gap by providing spirometry-controlled breath-hold. This approach:
- Ensures accurate, reproducible internal target positioning
- Enables Real-time lung air volume control and monitoring
- Allows enhanced sparing of adjacent healthy tissues
- Provides reliable synchronization of radiation beam delivery with breath-hold
These capabilities are essential for modern treatment techniques such as SBRT, IMRT, and proton therapy, where tight margins and high-dose precision are non-negotiable.
The Impact of SDX in Practice
In a 2024 treatment planning study conducted by an SDX user, the team evaluated the dosimetric benefits of breath-hold using the SDX System in Intensity Modulated Proton Therapy (IMPT) for a right lung tumor. The findings were compelling:
- Target volume was reduced by ~20% with SDX breath-hold
- Lung V20 decreased from 30% (non-BH) to 23% (BH)
- Mean heart dose dropped from 2.3 Gy to 1.1 Gy
> Source: Sabouri et al., 2024, Advances in Radiation Oncology.
These findings reflect what many clinicians already know through practice: motion matters, and it must be actively managed.
Advancing Standards in Tumor Targeting
With the shift toward hypofractionation, proton therapy, and cardiac-sparing techniques, clinicians are demanding more from their motion management systems. SDX delivers:
- Measured breath-hold precision
- Repeatable setup-to-delivery accuracy
- Compatibility with both manual and automated beam control
- Seamless integration into CT simulation and treatment delivery workflows
It is not simply about managing breathing. It is about ensuring tumor targeting confidence every step of the way.
When Precision Is Paramount
If your current protocols rely solely on SGRT or external surrogates for motion control, there is a risk that internal target variability may compromise dose delivery. SDX fills this gap by providing an internal, quantitative, and repeatable solution backed by peer-reviewed evidence and trusted by top-tier cancer centers. Because when every millimeter counts, beneath the surface, motion matters.
